{"paper_id": "a6009259cceb933dbbaa6456be281cf953d5137d", "metadata": {"title": "Journal Pre-proof Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay 2 3", "authors": [{"first": "Chao", "middle": [], "last": "Yan", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Jinghua", "middle": [], "last": "Cui", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Lei", "middle": [], "last": "Huang", "suffix": "", "affiliation": {"laboratory": "", "institution": "PLA General Hospital", "location": {"addrLine": "3 Beijing macro&micro-test Bio-Tech Co., Ltd. Beijing", "postCode": "100039, 101300", "settlement": "Beijing, 10", "country": "China, China"}}, "email": ""}, {"first": "Bing", "middle": [], "last": "Du", "suffix": "", "affiliation": {"laboratory": "", "institution": "Capital Institute of Paediatrics", "location": {"postCode": "100020", "settlement": "Beijing", "country": "China"}}, "email": ""}, {"first": "Lu", "middle": [], "last": "Chen", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Guanhua", "middle": [], "last": "Xue", "suffix": "", "affiliation": {"laboratory": "", "institution": "Capital Institute of Paediatrics", "location": {"postCode": "100020", "settlement": "Beijing", "country": "China"}}, "email": ""}, {"first": "Shaoli", "middle": [], "last": "Li", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Weiwei", "middle": [], "last": "Zhang", "suffix": "", "affiliation": {"laboratory": "", "institution": "Capital Institute of Paediatrics", "location": {"postCode": "100020", "settlement": "Beijing", "country": "China"}}, "email": ""}, {"first": "Linqing", "middle": [], "last": "Zhao", "suffix": "", "affiliation": {"laboratory": "", "institution": "Capital Institute of Paediatrics", "location": {"postCode": "100020", "settlement": "Beijing", "country": "China"}}, "email": ""}, {"first": "Yu", "middle": [], "last": "Sun", "suffix": "", "affiliation": {"laboratory": "", "institution": "Capital Institute of Paediatrics", "location": {"postCode": "100020", "settlement": "Beijing", "country": "China"}}, "email": ""}, {"first": "Hailan", "middle": [], "last": "Yao", "suffix": "", "affiliation": {"laboratory": "", "institution": "Capital Institute of Paediatrics", "location": {"postCode": "100020", "settlement": "Beijing", "country": "China"}}, "email": ""}, {"first": "Nannan", "middle": [], "last": "Li", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Hanqing", "middle": [], "last": "Zhao", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Yanling", "middle": [], "last": "Feng", "suffix": "", "affiliation": {"laboratory": "", "institution": "Capital Institute of Paediatrics", "location": {"postCode": "100020", "settlement": "Beijing", "country": "China"}}, "email": ""}, {"first": "Shiyu", "middle": [], "last": "Liu", "suffix": "", "affiliation": {"laboratory": "", "institution": "Capital Institute of Paediatrics", "location": {"postCode": "100020", "settlement": "Beijing", "country": "China"}}, "email": "liud@wh.iov.cn.20"}, {"first": "Qun", "middle": [], "last": "Zhang", "suffix": "", "affiliation": {"laboratory": "", "institution": "Capital Institute of Paediatrics", "location": {"postCode": "100020", "settlement": "Beijing", "country": "China"}}, "email": ""}, {"first": "Di", "middle": [], "last": "Liu", "suffix": "", "affiliation": {"laboratory": "", "institution": "Capital Institute of Paediatrics", "location": {"postCode": "100020", "settlement": "Beijing", "country": "China"}}, "email": ""}, {"first": "Jing", "middle": [], "last": "Yuan", "suffix": "", "affiliation": {"laboratory": "", "institution": "Capital Institute of Paediatrics", "location": {"postCode": "100020", "settlement": "Beijing", "country": "China"}}, "email": "yuanjing6216@163.com"}, {"first": "Yan", "middle": ["C"], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Cui", "middle": ["J"], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Huang", "middle": ["L"], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Du", "middle": ["B"], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Chen", "middle": ["L"], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Xue", "middle": ["G"], "last": "Li", "suffix": "", "affiliation": {}, "email": ""}, {"first": "S", "middle": [], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Zhang", "middle": ["W"], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Zhao", "middle": ["L"], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Sun", "middle": ["Y"], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Yao", "middle": ["H"], "last": "Li", "suffix": "", "affiliation": {}, "email": ""}, {"first": "N", "middle": [], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Zhao", "middle": ["H"], "last": "Feng", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Y", "middle": [], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Liu", "middle": ["S"], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Zhang", "middle": ["Q"], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Liu", "middle": ["D"], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Yuan", "middle": ["J"], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Yan", "middle": [], "last": "Chao", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Jinghua", "middle": [], "last": "1#", "suffix": "", "affiliation": {"laboratory": "", "institution": "Capital Institute of Paediatrics", "location": {"postCode": "100020", "settlement": "Beijing", "country": "China"}}, "email": ""}, {"first": "", "middle": [], "last": "Cui", "suffix": "", "affiliation": {"laboratory": "", "institution": "Capital Institute of Paediatrics", "location": {"postCode": "100020", "settlement": "Beijing", "country": "China"}}, "email": ""}, {"first": "Shaoli", "middle": [], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Li", "middle": [], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Hanqing", "middle": [], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Zhao", "middle": [], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "", "middle": ["Di"], "last": "Liu", "suffix": "", "affiliation": {"laboratory": "", "institution": "Capital Institute of Paediatrics", "location": {"postCode": "100020", "settlement": "Beijing", "country": "China"}}, "email": ""}, {"first": "", "middle": [], "last": "Wuhan", "suffix": "", "affiliation": {"laboratory": "", "institution": "Capital Institute of Paediatrics", "location": {"postCode": "100020", "settlement": "Beijing", "country": "China"}}, "email": ""}]}, "abstract": [{"text": "Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay, Clinical Microbiology and Infection, https://doi.Abstract 21 Objective. To evaluate a reverse transcription loop-mediated isothermal amplification 22 100% (95% CI 92.3% -100%), specificity 100% (95% CI 93.7% -100%). This assay 37 detected SARS-CoV-2 in the mean (\u00b1SD) time of 26.28 \u00b1 4.48 min and the results can 38 be identified with visual observation.", "cite_spans": [], "ref_spans": [], "section": "Abstract"}, {"text": "39", "cite_spans": [], "ref_spans": [], "section": "Abstract"}, {"text": "Conclusion. These results demonstrate that we developed a rapid, simple, specific, 40 and sensitive RT-LAMP assay for SARS-CoV-2 detection among clinical samples. It 41 will be a powerful tool for SARS-CoV-2 identification, and for monitoring suspected 42 patients, close contacts, and high-risk groups. 43 44 3", "cite_spans": [], "ref_spans": [], "section": "Abstract"}], "body_text": [{"text": "(RT-LAMP) assay for detection of SARS-CoV-2, and compare it with RT polymerase 23 chain reaction (RT-PCR).", "cite_spans": [], "ref_spans": [], "section": ""}, {"text": "Methods. We designed primers specific to the orf1ab and S genes of SARS-CoV-2. 25 Total viral RNA was extracted using the QIAamp Viral RNA Mini Kit. We optimized 26 the RT-LAMP assay. And, this assay was evaluated for its sensitivity and specificity of 27 detection using real-time turbidity monitoring and visual observation. The outbreak of a cluster of respiratory infections designated as coronavirus disease 46 2019 (COVID- 19) , caused by severe acute respiratory syndrome coronavirus 2 47 (SARS-CoV-2), had a significant impact on both the health and economy of the China 48 [1] [2] [3] [4] . To date (1 April 2020), up to 754, 948 SARS-CoV-2 cases have been confirmed, 49 including more than 36, 571 deaths (https://www.who.int/home). Human-to-human 50 transmission was confirmed through a case of five patients in a family cluster [5] . The 51 virus transmitted rapidly via aerial droplets, contact, and fomites [6] . 52 SARS-CoV-2 has been classified as a beta-coronavirus of group 2B with higher 53 similarity, over 96% identical at the whole-genome level, to two bat-derived The extracted RNAs were stored at -80\u00b0C. (Xiamen Zeesan Biotech Co., Ltd.) were also used. The copy number of the 98 pseudo-viruses was calculated using the following formula: copies/\u00b5L = 6.02\u00d7 10 23 99 \u00d710 -9 \u00d7 concentration(ng/\u00b5L) / (fragment length \u00d7 340). Then, 10-fold serial dilutions 100 of the pseudo-viruses ranging from 1\u00d710 8 copies/\u00b5L to 1 copy/\u00b5L were prepared. (Table S1 ).", "cite_spans": [{"start": 79, "end": 81, "text": "25", "ref_id": null}, {"start": 413, "end": 415, "text": "46", "ref_id": null}, {"start": 429, "end": 432, "text": "19)", "ref_id": null}, {"start": 582, "end": 585, "text": "[1]", "ref_id": "BIBREF0"}, {"start": 586, "end": 589, "text": "[2]", "ref_id": null}, {"start": 590, "end": 593, "text": "[3]", "ref_id": null}, {"start": 594, "end": 597, "text": "[4]", "ref_id": null}, {"start": 677, "end": 679, "text": "49", "ref_id": null}, {"start": 758, "end": 760, "text": "50", "ref_id": "BIBREF52"}, {"start": 840, "end": 843, "text": "[5]", "ref_id": null}, {"start": 850, "end": 852, "text": "51", "ref_id": "BIBREF53"}, {"start": 921, "end": 924, "text": "[6]", "ref_id": null}, {"start": 927, "end": 929, "text": "52", "ref_id": null}, {"start": 1007, "end": 1009, "text": "53", "ref_id": null}], "ref_spans": [{"start": 1462, "end": 1471, "text": "(Table S1", "ref_id": "TABREF1"}], "section": "24"}, {"text": "To screen for the optimum temperature, the reaction was incubated at five different 166 temperatures (60-64\u00b0C) for 60 min. As presented in Figure 1 , the highest 167 amplification efficiency occurred at 63\u00b0C. Therefore, 63\u00b0C was confirmed as the 168 optimum reaction temperature for this assay.", "cite_spans": [], "ref_spans": [{"start": 139, "end": 147, "text": "Figure 1", "ref_id": null}], "section": "165"}, {"text": "Sensitivity test for the RT-LAMP assay 170 The sensitivity of the RT-LAMP assay using primer sets orf1ab-4 and S-123 was 171 evaluated using turbidity monitoring and visual observation. Ten-fold serial dilutions 172 of the pseudo-viruses, ranging from 1\u00d710 8 copies/\u00b5L to 1 copy/\u00b5L (concentration of 173 template input) were detected by the RT-LAMP assays. As illustrated in Figure 2 taken for positive detection ranged from 20 min at 1\u00d710 8 copies /\u00b5L to 48 min at 177 1\u00d710 2 copies/\u00b5L . Thus, sensitivity of the assays was 2\u00d710 1 copies and 2\u00d710 2 copies 178 per reaction at 63 within 60 min with primer sets orf1ab-4 and S-123, respectively. The main findings of this study is that we established a rapid, sensitive, and 199 specific assay for SARS-CoV-2 detection by RT-LAMP. To improve the sensitivity, preparation [19] . The sensitivity of this assay was 20 copies per reaction, similar to 216 that reported for the RT-PCR assay in a previous study [20] . The RT-LAMP assay 217 showed no cross-reactivity with other respiratory pathogens, so the diagnostic 218 specificity of this method was higher than that reported for the serology test [21] .", "cite_spans": [{"start": 39, "end": 42, "text": "170", "ref_id": null}, {"start": 820, "end": 824, "text": "[19]", "ref_id": null}, {"start": 955, "end": 959, "text": "[20]", "ref_id": null}, {"start": 1146, "end": 1150, "text": "[21]", "ref_id": null}], "ref_spans": [{"start": 375, "end": 383, "text": "Figure 2", "ref_id": null}], "section": "169"}, {"text": "To assess the applicability of the assay for the clinical diagnosis of SARS-CoV-2, The main limitation of the current study is that we aligned only 103 complete 235 genomes of SARS-CoV-2 obtained from four databases when design the primers.", "cite_spans": [], "ref_spans": [], "section": "219"}, {"text": "With the spread of this virus, the accuracy of this RT-LAMP assay will be affected by 237 the mutations occurring in the primers sequence region of target gene. So, it is 238 necessary to monitor the mutant sites of virus genome by whole genome sequencing.", "cite_spans": [], "ref_spans": [], "section": "236"}, {"text": "The established RT-LAMP assay has important implications for clinical practice. The detection was monitored by turbidity using a Loopamp real-time turbidimeter, 17 and was judged by the naked eye depending on a color change from orange to green.", "cite_spans": [{"start": 161, "end": 163, "text": "17", "ref_id": null}], "ref_spans": [], "section": "239"}, {"text": "In B, 1-9: 10 8 , 10 7 , 10 6 , 10 5 , 10 4 , 10 3 , 10 2 , 10 1 , and 10 0 copies/\u00b5L. 19 In E, 1-8: 10 7 , 10 6 , 10 5 , 10 4 , 10 3 , 10 2 , 10 1 , and 10 0 copies/\u00b5L.", "cite_spans": [{"start": 87, "end": 89, "text": "19", "ref_id": null}], "ref_spans": [], "section": "18"}, {"text": "In C and F, 1-8: 10 8 , 10 7 , 10 6 , 10 5 , 10 4 , 10 3 , 10 2 , 10 1 , and 10 0 copies/\u00b5L.", "cite_spans": [], "ref_spans": [], "section": "20"}, {"text": "The reaction volume of 25 \u00b5L contained 2 \u00b5L RNA template, and the template 22 concentration was 1ng/\u00b5L. In the sensitivity test, 60 min can be used as the cut-off for 23 the visual detection. ", "cite_spans": [], "ref_spans": [], "section": "21"}], "bib_entries": {"BIBREF0": {"ref_id": "b0", "title": "The first two cases of 278 2019-nCoV in Italy: Where they come from", "authors": [{"first": "M", "middle": [], "last": "Giovanetti", "suffix": ""}, {"first": "D", "middle": [], "last": "Benvenuto", "suffix": ""}, {"first": "S", "middle": [], "last": "Angeletti", "suffix": ""}, {"first": "M", "middle": [], "last": "Ciccozzi", "suffix": ""}], "year": 2020, "venue": "J Med Virol", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1002/jmv.25699.279"]}}, "BIBREF2": {"ref_id": "b2", "title": "Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF5": {"ref_id": "b5", "title": "Washington State 2019-nCoV Case Investigation Team. First Case of", "authors": [], "year": 2019, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF6": {"ref_id": "b6", "title": "Coronavirus in the United States", "authors": [], "year": 2020, "venue": "N Engl J Med", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1056/NEJMoa2001191.285"]}}, "BIBREF8": {"ref_id": "b8", "title": "COVID-19) in France: surveillance, 287 investigations and control measures", "authors": [], "year": 2020, "venue": "Euro Surveill", "volume": "288", "issn": "2020", "pages": "", "other_ids": {"DOI": ["10.2807/1560-7917.ES.2020.25.6.2000094"]}}, "BIBREF9": {"ref_id": "b9", "title": "A familial cluster of infection associated 290 with the 2019 novel coronavirus indicating potential person-to-person transmission 291 during the incubation period", "authors": [{"first": "P", "middle": [], "last": "Yu", "suffix": ""}, {"first": "J", "middle": [], "last": "Zhu", "suffix": ""}, {"first": "Z", "middle": [], "last": "Zhang", "suffix": ""}, {"first": "Y", "middle": [], "last": "Han", "suffix": ""}, {"first": "L", "middle": [], "last": "Huang", "suffix": ""}], "year": 2020, "venue": "J Infect Dis", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF10": {"ref_id": "b10", "title": "World Health Organization. Novel coronavirus (2019-nCoV) situation report-7: 27 293", "authors": [], "year": 2020, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF11": {"ref_id": "b11", "title": "Genomic characterisation and 295 epidemiology of 2019 novel coronavirus: implications for virus origins and receptor 296 binding", "authors": [{"first": "R", "middle": [], "last": "Lu", "suffix": ""}, {"first": "X", "middle": [], "last": "Zhao", "suffix": ""}, {"first": "J", "middle": [], "last": "Li", "suffix": ""}, {"first": "P", "middle": [], "last": "Niu", "suffix": ""}, {"first": "B", "middle": [], "last": "Yang", "suffix": ""}, {"first": "H", "middle": [], "last": "Wu", "suffix": ""}], "year": 2020, "venue": "Lancet", "volume": "395", "issn": "", "pages": "565--74", "other_ids": {}}, "BIBREF12": {"ref_id": "b12", "title": "The global 298 spread of 2019-nCoV: a molecular evolutionary analysis", "authors": [{"first": "D", "middle": [], "last": "Benvenuto", "suffix": ""}, {"first": "M", "middle": [], "last": "Giovanetti", "suffix": ""}, {"first": "M", "middle": [], "last": "Salemi", "suffix": ""}, {"first": "M", "middle": [], "last": "Prosperi", "suffix": ""}, {"first": "De", "middle": [], "last": "Flora", "suffix": ""}, {"first": "C", "middle": [], "last": "", "suffix": ""}], "year": null, "venue": "Pathog Glob Health", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF14": {"ref_id": "b14", "title": "Divergence of the Novel Coronavirus (2019-nCoV) Originating in China", "authors": [], "year": 2020, "venue": "Cell Host 302 Microbe", "volume": "", "issn": "20", "pages": "", "other_ids": {}}, "BIBREF15": {"ref_id": "b15", "title": "Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert 305 laboratories in 30 EU/EEA countries", "authors": [{"first": "Cbem", "middle": [], "last": "Reusken", "suffix": ""}, {"first": "E", "middle": ["K"], "last": "Broberg", "suffix": ""}, {"first": "B", "middle": [], "last": "Haagmans", "suffix": ""}, {"first": "A", "middle": [], "last": "Meijer", "suffix": ""}, {"first": "V", "middle": ["M"], "last": "Corman", "suffix": ""}, {"first": "A", "middle": [], "last": "Papa", "suffix": ""}], "year": 2020, "venue": "Euro Surveill", "volume": "306", "issn": "2020", "pages": "", "other_ids": {"DOI": ["10.2807/1560-7917.ES.2020.25.6.2000082"]}}, "BIBREF17": {"ref_id": "b17", "title": "Loop-mediated isothermal amplification of DNA", "authors": [], "year": 2000, "venue": "Nucleic Acids Res", "volume": "309", "issn": "12", "pages": "", "other_ids": {}}, "BIBREF18": {"ref_id": "b18", "title": "Rapid and sensitive detection of 311 novel avian-origin influenza A (H7N9) virus by reverse transcription loop-mediated 312 isothermal amplification combined with a lateral-flow device", "authors": [{"first": "Y", "middle": [], "last": "Ge", "suffix": ""}, {"first": "B", "middle": [], "last": "Wu", "suffix": ""}, {"first": "X", "middle": [], "last": "Qi", "suffix": ""}, {"first": "K", "middle": [], "last": "Zhao", "suffix": ""}, {"first": "X", "middle": [], "last": "Guo", "suffix": ""}, {"first": "Y", "middle": [], "last": "Zhu", "suffix": ""}], "year": 2013, "venue": "PLoS One", "volume": "8", "issn": "", "pages": "313--69941", "other_ids": {}}, "BIBREF19": {"ref_id": "b19", "title": "A Rapid and Specific Assay 315 for the Detection of", "authors": [{"first": "P", "middle": [], "last": "Huang", "suffix": ""}, {"first": "H", "middle": [], "last": "Wang", "suffix": ""}, {"first": "Z", "middle": [], "last": "Cao", "suffix": ""}, {"first": "Jin", "middle": ["H"], "last": "Chi", "suffix": ""}, {"first": "H", "middle": [], "last": "Zhao", "suffix": ""}, {"first": "J", "middle": [], "last": "", "suffix": ""}], "year": 2018, "venue": "MERS-CoV. Front Microbiol", "volume": "9", "issn": "", "pages": "", "other_ids": {}}, "BIBREF20": {"ref_id": "b20", "title": "Visual detection of west nile 317 virus using reverse transcription loop-mediated isothermal amplification combined 318 with a vertical flow visualization strip", "authors": [{"first": "Z", "middle": [], "last": "Cao", "suffix": ""}, {"first": "H", "middle": [], "last": "Wang", "suffix": ""}, {"first": "L", "middle": [], "last": "Wang", "suffix": ""}, {"first": "L", "middle": [], "last": "Li", "suffix": ""}, {"first": "H", "middle": [], "last": "Jin", "suffix": ""}, {"first": "C", "middle": [], "last": "Xu", "suffix": ""}], "year": 2016, "venue": "Front Microbiol", "volume": "7", "issn": "", "pages": "", "other_ids": {}}, "BIBREF22": {"ref_id": "b22", "title": "Rapid and specific detection of Asian-and African-lineage Zika 321 viruses", "authors": [{"first": "C", "middle": [], "last": "Ruckert", "suffix": ""}], "year": 2017, "venue": "Sci Transl Med", "volume": "9", "issn": "", "pages": "", "other_ids": {}}, "BIBREF23": {"ref_id": "b23", "title": "Survey and Visual Detection of 323", "authors": [{"first": "H", "middle": [], "last": "Li", "suffix": ""}, {"first": "X", "middle": [], "last": "Wang", "suffix": ""}, {"first": "W", "middle": [], "last": "Liu", "suffix": ""}, {"first": "X", "middle": [], "last": "Wei", "suffix": ""}, {"first": "W", "middle": [], "last": "Lin", "suffix": ""}, {"first": "E", "middle": [], "last": "Li", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF24": {"ref_id": "b24", "title": "Zaire ebolavirus in Clinical Samples Targeting the Nucleoprotein Gene in Sierra 324", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF26": {"ref_id": "b26", "title": "A real-time 326 reverse transcription loop-mediated isothermal amplification assay for the rapid 327 detection of yellow fever virus", "authors": [{"first": "A", "middle": [], "last": "Kwallah", "suffix": ""}, {"first": "S", "middle": [], "last": "Inoue", "suffix": ""}, {"first": "A W", "middle": [], "last": "Muigai", "suffix": ""}, {"first": "T", "middle": [], "last": "Kubo", "suffix": ""}, {"first": "R", "middle": [], "last": "Sang", "suffix": ""}, {"first": "K", "middle": [], "last": "Morita", "suffix": ""}], "year": 2013, "venue": "J Virol Methods", "volume": "193", "issn": "", "pages": "23--30", "other_ids": {}}, "BIBREF27": {"ref_id": "b27", "title": "Loop-mediated isothermal amplification 329 (LAMP): principle, features, and future prospects", "authors": [{"first": "T", "middle": [], "last": "Notomi", "suffix": ""}, {"first": "Y", "middle": [], "last": "Mori", "suffix": ""}, {"first": "N", "middle": [], "last": "Tomita", "suffix": ""}, {"first": "H", "middle": [], "last": "Kanda", "suffix": ""}], "year": 2015, "venue": "J Microbiol", "volume": "53", "issn": "1", "pages": "", "other_ids": {}}, "BIBREF29": {"ref_id": "b29", "title": "Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR", "authors": [], "year": 2020, "venue": "Euro 332 Surveill", "volume": "25", "issn": "3", "pages": "", "other_ids": {}}, "BIBREF30": {"ref_id": "b30", "title": "Molecular 334 Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia", "authors": [{"first": "Dkw", "middle": [], "last": "Chu", "suffix": ""}, {"first": "Y", "middle": [], "last": "Pan", "suffix": ""}, {"first": "Sms", "middle": [], "last": "Cheng", "suffix": ""}, {"first": "Kpy", "middle": [], "last": "Hui", "suffix": ""}, {"first": "P", "middle": [], "last": "Krishnan", "suffix": ""}, {"first": "Y", "middle": [], "last": "Liu", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF32": {"ref_id": "b32", "title": "Molecular and 337 serological investigation of 2019-nCoV infected patients: implication of multiple 338 shedding routes", "authors": [{"first": "W", "middle": [], "last": "Zhang", "suffix": ""}, {"first": "R", "middle": ["H"], "last": "Du", "suffix": ""}, {"first": "B", "middle": [], "last": "Li", "suffix": ""}, {"first": "X", "middle": ["S"], "last": "Zheng", "suffix": ""}, {"first": "X", "middle": ["L"], "last": "Yang", "suffix": ""}, {"first": "B", "middle": [], "last": "Hu", "suffix": ""}], "year": 2020, "venue": "Emerg Microbes Infect", "volume": "9", "issn": "1", "pages": "386--389", "other_ids": {}}, "BIBREF33": {"ref_id": "b33", "title": "Clinical features of patients 340 infected with 2019 novel coronavirus in Wuhan, China", "authors": [{"first": "C", "middle": [], "last": "Huang", "suffix": ""}, {"first": "Y", "middle": [], "last": "Wang", "suffix": ""}, {"first": "X", "middle": [], "last": "Li", "suffix": ""}, {"first": "L", "middle": [], "last": "Ren", "suffix": ""}, {"first": "J", "middle": [], "last": "Zhao", "suffix": ""}, {"first": "Y", "middle": [], "last": "Hu", "suffix": ""}], "year": null, "venue": "Lancet", "volume": "341", "issn": "2020", "pages": "497--506", "other_ids": {}}, "BIBREF34": {"ref_id": "b34", "title": "A Novel Coronavirus 343 from Patients with Pneumonia in China", "authors": [{"first": "N", "middle": [], "last": "Zhu", "suffix": ""}, {"first": "D", "middle": [], "last": "Zhang", "suffix": ""}, {"first": "W", "middle": [], "last": "Wang", "suffix": ""}, {"first": "X", "middle": [], "last": "Li", "suffix": ""}, {"first": "B", "middle": [], "last": "Yang", "suffix": ""}, {"first": "J", "middle": [], "last": "Song", "suffix": ""}], "year": 2019, "venue": "N Engl J Med", "volume": "382", "issn": "8", "pages": "727--760", "other_ids": {}}, "BIBREF36": {"ref_id": "b36", "title": "Genetic Diagnostic Methods for Novel Coronavirus 2019 (nCoV-2019) in Japan", "authors": [], "year": 2020, "venue": "J Infect Dis", "volume": "347", "issn": "", "pages": "", "other_ids": {"DOI": ["10.7883/yoken.JJID.2020.061"]}}, "BIBREF37": {"ref_id": "b37", "title": "RNA based mNGS approach 349 identifies a novel human coronavirus from two individual pneumonia cases", "authors": [{"first": "L", "middle": [], "last": "Chen", "suffix": ""}, {"first": "W", "middle": [], "last": "Liu", "suffix": ""}, {"first": "Q", "middle": [], "last": "Zhang", "suffix": ""}, {"first": "K", "middle": [], "last": "Xu", "suffix": ""}, {"first": "G", "middle": [], "last": "Ye", "suffix": ""}, {"first": "W", "middle": [], "last": "Wu", "suffix": ""}], "year": 2019, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF38": {"ref_id": "b38", "title": "Wuhan outbreak", "authors": [], "year": 2020, "venue": "Emerg Microbes Infect", "volume": "9", "issn": "1", "pages": "313--319", "other_ids": {}}, "BIBREF40": {"ref_id": "b40", "title": "Load in Upper Respiratory Specimens of Infected Patients", "authors": [], "year": null, "venue": "N Engl J Med", "volume": "353", "issn": "2020", "pages": "", "other_ids": {"DOI": ["10.1056/NEJMc2001737"]}}, "BIBREF41": {"ref_id": "b41", "title": "HCoV-NL63-3; S6: HCoV-OC43-1; S7: HCoV-OC43-2; S8: HCoV-HKU1-1", "authors": [], "year": null, "venue": "", "volume": "9", "issn": "", "pages": "", "other_ids": {}}, "BIBREF43": {"ref_id": "b43", "title": "ADV-1-2; S29: ADV-2-1", "authors": [], "year": null, "venue": "", "volume": "25", "issn": "", "pages": "39--41", "other_ids": {}}, "BIBREF44": {"ref_id": "b44", "title": "A-2; S41: RSV B-1; S42: RSV B-2; S43: HMPV-1; S44: HMPV-2; S45: BoV-1", "authors": [], "year": null, "venue": "", "volume": "46", "issn": "", "pages": "", "other_ids": {}}, "BIBREF45": {"ref_id": "b45", "title": "BoV-2; S47: Rh A-1; S48: RhA-2; S49: Rh B-1; S50: RhB-2; S51: Rh C-1", "authors": [], "year": null, "venue": "", "volume": "52", "issn": "", "pages": "", "other_ids": {}}, "BIBREF47": {"ref_id": "b47", "title": "S56: Klebsiella pneumoniae; S57: Streptococcus pneumoniae; S58: Pseudomonas 45 aeruginosa", "authors": [], "year": null, "venue": "", "volume": "59", "issn": "", "pages": "", "other_ids": {}}, "BIBREF50": {"ref_id": "b50", "title": "Figure 1 Sequence comparison and gene analysis of the orf1b and S genes 49", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF51": {"ref_id": "b51", "title": "Sequence comparison and gene mutation analysis of the orf1b gene (8084bp)", "authors": [{"first": "A", "middle": [], "last": "", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF52": {"ref_id": "b52", "title": "Sequence comparison and gene mutation analysis of the S gene (3822bp)", "authors": [{"first": "B", "middle": [], "last": "", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF53": {"ref_id": "b53", "title": "F3: outer forward primer; B3: outer backward primer; FIP: forward inner primer; BIP: 52 backward inner primer; LF: loop forward primer", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF55": {"ref_id": "b55", "title": "Bat severe acute respiratory syndrome like coronavirus 55 MERS: Middle East respiratory syndrome coronavirus", "authors": [{"first": "-Sl-Cov", "middle": [], "last": "Bat", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF56": {"ref_id": "b56", "title": "GenBank Accession No. MG772933; Bat-SL-CoVZC45", "authors": [{"first": "-Sl-Covzc45", "middle": [], "last": "Bat", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF58": {"ref_id": "b58", "title": "GenBank Accession No. NC_019843.3", "authors": [{"first": "", "middle": [], "last": "Nc_004718.3; Mers-Cov", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}}, "ref_entries": {"FIGREF0": {"text": "The primer sets orf1ab-4 and S-123 amplified the genes in the shortest times, 29 the mean (\u00b1SD) time was 18 \u00b1 1.32 min and 20 \u00b1 1.80 min, respectively, and 63\u00b0C30 was the optimum reaction temperature. The sensitivity was 2\u00d710 1 copies and 2\u00d710 2 31 copies per reaction with primer sets orf1ab-4 and S-123, respectively. This assay 32 showed no cross-reactivity with other 60 respiratory pathogens. To describe the 33 availability of this method in clinical diagnosis, we collected 130 specimens from 34 patients with clinically suspected SARS-CoV-2 infection. Among them, 58 were 35 confirmed to be positive and 72 were negative by RT-LAMP. The sensiticity was 36 Introduction 45", "latex": null, "type": "figure"}, "FIGREF1": {"text": "54 coronavirus strains than to other known HCoVs [7,8]. The genome of the novel virus 55 comprises a 5' untranslated region (UTR), replicase complex (orf1ab), Spike gene (S 56 gene), E gene, M gene, N gene, 3' UTR, and several unidentified non-structural open 57 reading frames [9]. 58 Since the outbreak of SARS-CoV-2 infection, real-time reverse 59 transcription-polymerase chain reaction (RT-PCR) assays have played an important 60 role in clinical diagnosis and the investigation of suspected cases. However, such 61", "latex": null, "type": "figure"}, "FIGREF2": {"text": "of 60 respiratory pathogens including human coronavirus HCoV-229E, 80 HCoV-NL63, HCoV-OC43, HCoV-HKU1, SARS-CoV (pseudo-virus), and 81 MERS-CoV (pseudo-virus); influenza A-H3N2, H1N1, influenza Bvirus (RSV) type A/B, human metapneumovirus (HMPV), human bocavirus 84 (BoV), rhinovirus (Rh) type A/B/C, as well as respiratory pathogens such as 85 Mycoplasma pneumoniae (MP) strain M129/FH, Haemophilus influenzae ATCC 86 49247, Staphylococcus aureus, Klebsiella pneumoniae, Streptococcus pneumoniae, 87and Pseudomonas aeruginosa were used in this study.", "latex": null, "type": "figure"}, "FIGREF3": {"text": "RNA was extracted from the specimens using the QIAamp Viral RNA90    Mini Kit (Qiagen, Hilden, Germany), according to the manufacturer's instructions.", "latex": null, "type": "figure"}, "FIGREF5": {"text": "Preparation of the artificial SARS-CoV-2 gene 93 The full-length 3,822 bp spike gene (21563-25384) and a 500 bp sequence 94 (13,791-14290) of the orf1ab gene of SARS-CoV-2 (GenBank Accession No. 95 MN908947.3) were synthesized (Sangon Biotec Co., Ltd., Shanghai, China) and 96 cloned into vector pUC57. Pseudo-viruses of 2019-nCov-S and 2019-nCov-ORF1ab 97", "latex": null, "type": "figure"}, "FIGREF6": {"text": "103 complete genomes of SARS-CoV-2 obtained from four databases, 103 GenBank, GISAID, GWH, and NMDC (https://bigd.big.ac.cn/ncov), to confirm the 104 conservation of the selected sequence. Homology analysis was conducted using 105 BLAST (National Centre for Biotechnology Information). Five sets of primers 106 specific to the orf1ab and S genes were respectively designed using the software 107 PrimerExplorer V5 at the website: http://primerexplorer.jp/e/. The primers included an 108 outer forward primer (F3), an outer backward primer (B3), a forward inner primer 109 (FIP), and a backward inner primer (BIP). A loop forward primer (LF) and/or a loop", "latex": null, "type": "figure"}, "FIGREF7": {"text": "were synthesized by Shanghai Invitrogen Biological Engineering, Co., 116 Ltd. and purified by high-performance liquid chromatography (HPLC).", "latex": null, "type": "figure"}, "FIGREF8": {"text": "Loopamp RNA amplification kit (Eiken Chemical Co., Ltd., Tokyo, Japan) was 119 used to perform the RT-LAMP reaction. The reaction volume of 25 \u00b5L contained 120 2\u00d7Reaction Mix 12.5 \u00b5L, Enzyme Mix (a mix of Bst DNA polymerase and AMV 121 reverse transcriptase) 1.0 \u00b5L, primers FIP and BIP 40 pmol, primers F3 and B3 5 122 pmol, primers LF and/or LB 20 pmol, fluorescent detection reagent 1 \u00b5L (when 123 needed), and template RNA 2 \u00b5L. The mixture was incubated at 63\u00b0C for 60 min. The 124 process was monitored using a Loopamp Real-time Turbidimeter (LA-230; Eiken 125 Chemical Co., Ltd., Tochigi, Japan). Turbidity readings at an optimal density at 650 126 nm (OD650) were obtained every 6 seconds, and the reaction was considered positive 127 when the turbidity values were over 0.1. For visual observation, 1 \u00b5L of fluorescent 128 calcein was added to the mixture, and a colour change from orange to green was 129 observed by the naked eye for a positive reaction.", "latex": null, "type": "figure"}, "FIGREF9": {"text": "Real-time RT-PCR assay131    A commercial real-time RT-PCR kit (BGI PathoGenesis Pharmaceutical132 7 Technology, Shenzhen, China) was used as a gold-standard of the RT-LAMP. The 133 total reaction volume was 30 \u00b5L and the reaction was set up according to the 134 manufacturer's protocol. The reaction procedure was 50\u00b0C for 20 min, 95\u00b0C for 10 135 min, followed by 40 cycles of 95\u00b0C for 15 s and 60\u00b0C for 30 s. A threshold cycle (Ct 136 value) <38 was determined to indicate a positive sample. 137 Clinical Specimens 138 One hundred and thirty clinical specimens were collected from patients with 139 pneumonia and suspected SARS-CoV-2 infection, including swabs and 140 bronchoalveolar lavage fluid. Initial process of all specimens was handled in a 141 validated biological safety cabinet, and performed by staff trained with appropriate 142 personal protective equipment. The extracted RNA was divided into two parts for 143 amplification. The RT-LAMP assays and real-time RT-PCR were performed 144 simultaneously in a biosafety level 2 laboratory, as detailed in the WHO Laboratory 145 biosafety manual, 3 rd edition. The amplified products of the RT-LAMP were detected 146 by turbidity monitoring as well as visual observation. To assess turbidity, the time of 147 the positivity detection was counted. Mean and standard deviation were used to 148 describe the data and 95% CI were presented where relevant. This work was approved 149 by the research board of the Ethics Committee of the Capital Institute of Paediatrics, 150 Beijing, China. All patients provided informed consent in accordance with the 151 Declaration of Helsinki.", "latex": null, "type": "figure"}, "FIGREF10": {"text": "the RT-LAMP assay 154 8The conserved regions of the orf1ab gene and S gene of SARS-CoV-2 with low 155 mutation frequencies were candidate target sequences (Figure S1). The 156 pseudo-viruses were used as the template (the concentration was 1ng/\u00b5L) to optimize 157 the RT-LAMP reaction conditions. Five sets of primers were designed to respectively 158 detect the orf1ab gene (orf1ab-212, orf1ab-4, orf1ab-33, orf1ab-22, and orf1ab-1) and 159 the spike gene (S-107, S-123, S-67, S-41, and S-61) of SARS-CoV-2 using a real-time 160 LAMP turbidimeter. As shown inFigure 1, the primer sets orf1ab-4 and S-123 161 amplified the genes in the shortest times, the mean (\u00b1SD) time was 18 \u00b1 1.32 min and 162 20 \u00b1 1.80 min, respectively, so these two sets of primers were chosen as the optimal 163 primers for RT-LAMP detection. All of the primer sets used in this study are listed 164", "latex": null, "type": "figure"}, "FIGREF11": {"text": "taken for positive detection ranged from 17 min at 1\u00d710 8 copies/\u00b5L to 46 min at 175 1\u00d710 1 copies/\u00b5L using primer set orf1ab-4, whereas for primer set S-123, the time176 9", "latex": null, "type": "figure"}, "FIGREF12": {"text": "The detection limit was the same with visual observation, with all positive reactions 180 changing to green and negative reactions remaining orange as observed by the naked 181 eye. But sensitivity of the conventional PCR was 2\u00d710 2 copies and 2\u00d710 3 copies per 182 reaction with primer sets orf1ab-4 and S-123, respectively.183Specificity test for RT-LAMP assay184    The specificity of the RT-LAMP assays was evaluated using 60 strains of human185 respiratory pathogens. Figure 3 reveals that only the pseudo-viruses tested positive, 186 the nucleic acids of other respiratory pathogens and the blank control all tested 187 negative by the RT-LAMP assay with primer sets orf1ab-4 and S-123, using turbidity 188 monitoring and visual observation. Therefore, the RT-LAMP assay showed no 189 cross-reactivity with other respiratory pathogens.", "latex": null, "type": "figure"}, "FIGREF13": {"text": "swabs and bronchoalveolar lavage fluid samples obtained from patients 192 with pneumonia and suspected SARS-CoV-2 infection were simultaneously detected 193 by RT-LAMP with the two primer sets (orf1ab-4 and S-123) and real-time RT-PCR. 194 Among them, 58 patients were confirmed to be infected with SARS-CoV-2, while 72 195 tested negative (", "latex": null, "type": "figure"}, "FIGREF14": {"text": "200 we chose two target genes, orf1ab and S, to detect viral RNA in clinical samples. To 201 ensure the stability of the detection assay, we aligned 103 complete virus genomes, 202 then we selected conversed regions without gene mutations in the orf1ab (245 bp) and 203 S (216 bp) genes. To reduce the reaction time, we designed loop primers. Briefly, six 204 primers targeting eight regions generated a self-priming dumbbell-shaped template 205 upon isothermal incubation with strand-displacing polymerase, resulting in the rapid 206 production of large quantities of complex amplicon [18]. 207 Since the release of the first SARS-CoV-2 genome sequence via the community 208 online resource, virological.org, on 10 January (Wuhan-Hu-1, GenBank accession: 209 MN908947), more than 2,500 coronavirus sequences have been uploaded to date. 210 These data make it possible for researchers to develop assays to detect viral RNA, to 211 quarantine the source of infection, to explore the origin and native host(s), and to 212 reveal the likely receptor-binding properties of this novel coronavirus-SARS-CoV-2. 213 The novel RT-LAMP assay presented positive results in the mean (\u00b1SD) time of 214 26.28 \u00b1 4.48 min, whereas the RT-PCR assay requires 1-2 h after viral RNA 215", "latex": null, "type": "figure"}, "FIGREF15": {"text": ". In fact, compared with the RT-PCR method, the RT-LAMP is easy 222 to handle, does not require skilled personnel or specialized instruments. The visual 223 RT-LAMP assay can rapidly complete detection within 60 min, which was faster than 224 RT-PCR assay which required more than 80 min. In addition, the positive results was 225 visual directly and easier to observe.226 Strengths of this study include that the RT-LAMP assay is an important 227 point-of-care testing (POCT) detection method. The results are easy to read. The 228 positive results could be judged by the naked eye according to a colour change from 229 orange to green, while the negative results remained orange, illustrating the obvious 230 benefits. Moreover, the designed RT-LAMP primers targeted five/ six independent 231 regions. And the new method can detect the virus in a single step at a constant 232 temperature of 63 , so the assay can be performed using a small instrument. At the 233 bedside or in the field.", "latex": null, "type": "figure"}, "FIGREF17": {"text": "Coronavirus disease 2019 is widely distributed throughout 203 countries, areas or 241 territories, and the number of confirmed cases and deaths continue to rise[22,23].", "latex": null, "type": "figure"}, "FIGREF18": {"text": "outbreak and to select appropriate treatment. At present, RT-PCR was244    widely applied for clinical diagnosis[19][20][24][25]. However, there are various 245 drawbacks to this methodology, such as low sensitivity, the occurrence of false246 negatives, and virus loading in oral swabs [26]. As a result of time constraints and 247 clinical needs, the quality of the commercial kits has not been further verified and 248 evaluated using a large number of clinical samples. The RT-PCR assay is also 249 laborious to perform, time-consuming, and requires specialized equipment. To 250 overcome these problems, a more rapid, convenient, and less complex assay is 251 needed. 252 In conclusion, we developed a RT-LAMP assay for SARS-CoV-2 detection that 253 demonstrated high diagnostic sensitivity and specificity among clinical samples. The 254 RT-LAMP assay is a powerful tool for SARS-CoV-2 identification not only in 255 experimental laboratories, but also in hospitals as it does not require complex 256 equipment. It may prove useful in monitoring suspected patients, close contacts, and 257 high-risk groups. 258 Conflicts of Interest\uff1a \uff1a \uff1a \uff1aAll authors disclose no conflicts of interest. 259 Funding 260 This work was supported by grants from the National Natural Science Foundation of 261 China [grant number 31670035], Mega-projects of Science and Technology Research 262 of China [grant numbers2017ZX100102, 2018ZX10101-003-002] to J.Y., and CAMS 263 innovation Fund for Medical Sciences (CIFMS) [grant number2016-I2M-1-008], are grateful to Weijun Chen of Beijing macro&micro test Biotech company and 268 Yiming Li of Chinese PLA General Hospital for providing and detecting the clinical 269 samples from COVID-2019 patients and controls. We thank Kate Fox, DPhil, from 270 Liwen Bianji, Edanz Group China (www.liwenbianji.cn/ac), for editing the English 271 text of a draft of this manuscript. 272 Contribution of authors 273 JY and DL designed the experiments, and edited the manuscript. CY, JC, BD, GX, SL, 274 and WZ performed and developed the RT-LAMP. HY, LH, LC, LZ, YS, NL, HZ, YF, 275 SL, and QZ performed the experiments. CY and JC wrote the manuscript.", "latex": null, "type": "figure"}, "FIGREF19": {"text": "The Most appropriate primers and reaction temperature for the reverse 2 transcription loop-mediated isothermal amplification (RT-LAMP) assay 3 A: The most suitable primer set for the RT-LAMP assay to amplify the orf1ab gene; 4 B: The optimal reaction temperature for the RT-LAMP assay with primer orf1ab-4; 5 C: The most suitable primer set for the RT-LAMP assay to amplify the S gene.6 D: The optimal reaction temperature for the RT-LAMP assay with primer S-123. Sensitivity of the reverse transcription loop-mediated isothermal 8 amplification (RT-LAMP) assay and conventional PCR for SARS-CoV-2 9 detection 10 A, B: Sensitivity of the RT-LAMP assay using primer set orf1ab-4 to target the orf1ab 11 gene for SARS-CoV-2 detection; 12 D, E:Sensitivity of the RT-LAMP assay using primer set S-123 to target the S gene for 13 SARS-CoV-2 detection; 14 C, F:Sensitivity of the conventional PCR assay targeting the orf1ab and S genes for 15 SARS-CoV-2 detection; 16", "latex": null, "type": "figure"}, "FIGREF20": {"text": "Specificity of the reverse transcription loop-mediated isothermal 25 amplification (RT-LAMP) assay for SARS-CoV-2 detection 26 A, B: Specificity of the RT-LAMP assay with primer set orf1ab-4 targeted the orf1ab 27 gene for SARS-CoV-2 detection; 28 C, D: Specificity of the RT-LAMP assay with primer set S-123 targeted the S gene for 29 SARS-CoV-2 detection. 30 The detection was monitored by turbidity using a Loopamp real-time turbidimeter 31 (A1, B1), and was judged by the naked eye depending on a color change from orange 32 to green (A2, B2). 33 S1: HCoV-229E-1; S2: HCoV-229E-2; S3: HCoV-NL63-1; S4: HCoV-NL63-2; S5: 34 Table 1 Comparison between the reverse transcription loop-mediated isothermal amplification assay and reverse transcription-polymerase chain reaction for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-72 (no change in color) 72 (no change in color) 72 (no peak) a RT-LAMP: reverse transcription loop-mediated isothermal amplification b RT-PCR: reverse transcription-polymerase chain reaction c SD: standard deviation d range: the shortest detection time -the longest detection time", "latex": null, "type": "figure"}, "TABREF0": {"text": "methods are laborious, time-consuming, require specialized instruments, and are therefore not able to satisfy the current rapid growth and demands of testing the large number of suspected patients, asymptomatic patients, and close contacts.A rapid, simple, and sensitive assay is urgently needed [10]. Loop-mediated isothermal amplification (LAMP) was developed by Notomi et al. in 2000 [11]. It is a rapid, sensitive, and effective visual nucleic acid amplification method. Recently, this method has been widely applied for the detection of influenza virus, MERS-CoV, West Nile virus, Ebola virus, Zika virus, yellow fever virus, and a variety of other pathogens [12-17]. The test relies on auto-cycling strand displacement DNA synthesis using four to six specific primers to recognize six to eight sequences of the target gene in only 1 hour.In this study, we developed a reverse transcription LAMP (RT-LAMP) assay to detect SARS-CoV-2 in patients with COVID-19. We designed five sets of primers that target the orf1ab gene and the spike gene for optimization of the assay. We also 75 evaluated the sensitivity and specificity of this method. Finally, 130 clinical samples collected from patients were analysed for clinical diagnosis.", "latex": null, "type": "table"}, "TABREF1": {"text": ". The sensiticity was 100% (95% CI 92.3% -100%),", "latex": null, "type": "table"}}, "back_matter": []}